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Recently developed heavy ion irradiation therapy using a carbon beam (CB) against systemic malignancy has numerous
advantages. However, the clinical results of CB therapy against glioblastoma still have room for improvement. Therefore, we
tried to clarify the molecular mechanism of CB-induced glioma cell death. T98G and U251 human glioblastoma cell lines were
irradiated by CB, and caspase-dependent apoptosis was induced in both cell lines in a dose-dependent manner. Knockdown of
Bax(BCL-2-associatedXprotein)andBak(BCL-2-associatedkiller)andoverexpressionofBcl-2orBcl-xl(B-celllymphoma-extra
large) showed the involvement of Bcl-2 family proteins upstream of caspase activation, including caspase-8, in CB-induced
glioma cell death. We also detected the activation of extracellular signal-regulated kinase (ERK) and the knockdown of ERK
regulator mitogen-activated protein kinase kinase (MEK)1/2 or overexpression of a dominant-negative (DN) ERK inhibited
CB-induced glioma cell death upstream of the mitochondria. In addition, application of MEK-speciﬁc inhibitors for deﬁned
periodsshowedthatthe recoveryofactivationofERKbetween2and36hafter irradiationis essentialforCB-inducedglioma cell
death. Furthermore, MEK inhibitors or overexpression of a DN ERK failed to signiﬁcantly inhibit X-ray-induced T98G and U251
cell death. These results suggested that the MEK–ERK cascade has a crucial role in CB-induced glioma cell death, which is
known to have a limited contribution to X-ray-induced glioma cell death.
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Since the ﬁrst clinical trial in 1994, the efﬁcacy of high linear
energy transfer (LET) heavy ion therapy using a carbon beam
(CB) has been proven in various cancer treatments, including
cases of radioresistant tumors.
1,2 Compared with conven-
tional low-LET radiotherapy, high-LET CB therapy has
numerous therapeutic advantages. Furthermore, CB offers
ideal energy distribution around the Bragg peak, which
induces a maximum ionizing effect in the pathological lesion
and less damage to the surrounding normal tissue, leading to
better tumor controllability with shorter treatment times and
fewer side effects.
1,3–5
Similar to other radioresistant tumors, the therapeutic
approach for cerebral malignant glioma, which has one of
the poorest prognoses among systemic tumors because of its
extremely high resistance to various chemotherapeutic and
radiotherapeutic approaches,
6 the use of CB therapy had
already started an early phase of development.
7 Although
intracranial chordoma indicated an excellent outcome after
CB treatment (overall survival 89.4% per 3 years) compared
with conventional radiotherapy,
8 the results of glioma therapy
by CB irradiation were not considered to be better.
As CB-irradiation therapy was developed relatively recently
and a very limited number of heavy ion accelerators exist
across the world, the accumulation of evidence regarding the
molecular mechanism of CB-induced tumor cell death is
ongoing. A wide variety of modes of glioma cell death induced
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www.nature.com/cddisby conventional radiotherapy have been reported, including
apoptosis,
9,10 necrotic cell death,
10 and autophagic cell
death.
11 On the other hand, from several reports showing
the mechanism of CB irradiation-induced death of tumor
cells, including glioma cells, details of the characteristics/
mechanism of CB irradiation-induced glioma cell death are
still unknown. Therefore, further understanding of the
mechanism of CB irradiation-induced glioma cell death could
improve the prospects for clinical glioma therapy using CB
irradiation.
In this study, we explored the detailed molecular mechanism
of CB irradiation-induced glioma cell death, including the
mode of cell death, the involvement of major intracellular cell
death signal cascades, and CB irradiation-speciﬁc cell death
signal transducers, to improve CB-irradiation therapy in
glioma treatment and to achieve better clinical outcomes.
Results
CB irradiation induces cell death of human glioma cell
lines with apoptotic features in a dose-dependent
manner. First, to investigate the characteristics/mechanism
of CB irradiation-induced glioma cell death, we determined
the conditions of CB irradiation treatment that induced
moderate glioma cell death. Therefore, to determine the
appropriate irradiation dose, T98G and U251 human glioma
cells were irradiated with a 1–10Gy CB, which is near the
clinical CB irradiation dose for glioma therapy.
7 As a result,
induction of cell death in both cell lines was conﬁrmed in a
dose-dependent manner at 48h after irradiation
(Supplementary Figure 1a). Nuclear staining with propidium
iodide (PI) for quantitation of cell death also showed the
irradiation dose dependency of CB irradiation-induced cell
death (Figure 1a, left), as observed in phase-contrast
images. Next, to investigate the characteristics of CB
irradiation-induced cell death, we tried to detect apoptosis,
which is the typical form of programmed cell death,
12 by
additional staining of the nuclei using Hoechst 33342 and by
a DNA ladder formation assay. As a result, cells with
apoptotic nuclear morphology corresponding to PI-positive
cells also increased in an irradiation dose-dependent manner
in both types of CB-irradiated cells (Figure 1a, right), and
DNA ladder formation was observed as well (Supplementary
Figure 1b). From these results, it was suggested that
CB irradiation triggers apoptotic cell death in human glioma
cells.
As both T98G cells and U251 cells are p53 mutated, which
acts as a DNA damage sensor and has a critical role in DNA
damage-induced cell death,
13 the above results suggested
thatCB-inducedgliomacell deathmaynotnecessarilyrequire
the p53 activity. Consistent with this idea, CB irradiation did
not increase p53 expression (Supplementary Figure 1c). On
the other hand, we asked whether another intracellular
damage signal initiator, endoplasmic reticulum (ER) stress,
14
could be involved in CB-induced glioma cell death. As shown
in Supplementary Figure 1c, CB irradiation did not induce the
expression of an ER stress marker GRP78, suggesting that
the ER stress response may not have a role in CB-induced
glioma cell death.
Multiple caspases are involved in CB irradiation-induced
cell death. Usually, caspases have a crucial role in the ﬁnal
step of apoptosis; therefore, we investigated the activation of
various caspases in CB irradiation-induced cell death. Time
kinetics analysis of caspase-9, caspase-3, and caspase-8
showed not only the activation of caspase-9 and caspase-3,
which are mainly implicated in the intrinsic pathway, but also
that of caspase-8, which is mainly implicated in the extrinsic
pathway,
12 and these caspases were activated from 48h
after irradiation (Figure 1b and c). In addition, processing of
the major effector caspase substrate poly-ADP ribose
polymerase (PARP), cytochrome c release to the cytosol
from the mitochondria, and processing of the caspase-8
substrate Bcl-2 interacting domain death agonist (Bid) were
also observed (Figure 1b and c). Taken together, multiple
caspases are activated upon the induction of glioma cell
death by CB irradiation. Next, to investigate the functional
involvement of these caspases, we used pan-caspase
inhibitors or speciﬁc inhibitors of each caspase and
evaluated their effect on CB irradiation-induced T98G and
U251 cell death. As a result, pan-caspase inhibitors blocked
CB irradiation-induced caspase activation, processing of
PARP, apoptosis, and cell death of T98G and U251
effectively, whereas each speciﬁc caspase inhibitor
Figure 1 CB irradiation induces multiple caspase-dependent apoptosis in T98G and U251 glioma cells. (a) T98G and U251 cells treated with or without CB irradiation at
the indicated doses were stained with Hoechst 33342 or propidium iodide (PI), and the percentages of dead cells and apoptotic/dead cells were counted using a microscope,
asdescribedin the‘Materialsandmethods’sectionat48h afterirradiation. (b)T98GandU251cellswereCBirradiated(5Gy)andharvestedat theindicatedtimepointsafter
irradiation. The whole-cell lysates obtained were subjected to immunoblotting using the indicated antibodies. As a control of irradiation and DNA damage-induced responses,
total cell lysates of T98G and U251 cells obtained at the indicated time periods after X-ray irradiation (20Gy) or UVC (UV, 200J) were also subjected to immunoblotting using
the same antibodies. The membranes were reprobed using an a-tubulin antibody to conﬁrm equal protein loading. For the detection of cytochrome c release from the
mitochondria into the cytosol,T98G and U251 cells were treatedby the same stimuli,and then cell lysates obtainedat theindicatedtime points were fractionatedinto cytosol-
and mitochondria-rich fractions as described in the ‘Materials and methods’ section and were subjected to immunoblotting using an anti-cytochrome c antibody. To check for
equal protein loading, the membranes were reprobed using organelle-speciﬁc antibodies (anti-a-tubulin for the cytosol and anti-HSP60 for the mitochondria). (c) T98G and
U251 cells were CB irradiated (5Gy) and harvested at the indicated time points after irradiation. The total cell lysates obtained were subjected to immunoblotting using anti-
caspase-8 and anti-Bid antibodies. As a control for extrinsic pathway activation, whole-cell lysates obtained from T98G and U251 cells 48h after irradiation by X-ray (X-ray,
20Gy) or treatment with tumor necrosis factor (TNF) 1000IUþcycloheximide (CHX) 10mg/ml were also subjected to immunoblotting using the same antibodies. The
membranes were reprobed with an anti-a-tubulin to conﬁrm equal protein loading. (d) T98G and U251 cells pretreated with pan-caspase inhibitors (z-VAD-FMK (VAD,
200mM) or Boc-D-FMK (Boc, 200mM)) or speciﬁc caspase inhibitors (z-DEVD-CHO (DEVD, 200mM, for caspase-3), z-LEHD-CHO (LEHD, 200mM, for caspase-9), or z-
IETD-CHO (IETD, 200mM, for caspase-8)) for 2h were CB irradiated (5Gy) and subjected to quantitation of apoptosis and cell death as described in panel at 48h after
irradiation(*Po0.05).Totalcelllysatesfromcellstreatedinthesamemannerat48hafterirradiationweresubjectedto immunoblottingusinganti-caspase-3, anti-caspase-9,
anti-caspase-8, and anti-PARP antibodies. The membranes were reprobed using an anti-a-tubulin antibody to conﬁrm equal protein loading
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Cell Death and Diseasesuppressed CB irradiation-induced glioma cell death
efﬁciently but not as much as pan-caspase inhibitors
(Figure 1d). These results suggested that caspases are
functionally essential for CB irradiation-induced T98G and
U251 glioma cell death.
Bcl-2 family proteins regulate CB-induced caspase
activation and apoptosis of glioma cells at the
mitochondrial level. In considering the caspase activation
mechanism, the mitochondria are the key intracellular
organelle that relays caspase cascade-activating signals.
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Cell Death and DiseaseTherefore, we investigated the involvement of the
mitochondria. As proapoptotic Bcl-2 family proteins,
especially multidomain type proapoptotic Bcl-2 family
proteins BCL-2-associated X protein (Bax) and BCL-2-
associated killer (Bak), have an essential role in cell death
triggered by diverse cell death stimuli through the
mitochondria,
12,15 we monitored Bax and Bak activation,
which is necessary for mitochondrial outer membrane
permeabilization and transduction of the cell death signal
by the mitochondria. Upon activation, Bax translocates from
the cytosol to the mitochondrial outer membrane and forms a
self-oligomer, and Bak, which is originally localized to the
mitochondrial outer membrane, also forms a pore-forming
oligomer in the mitochondrial outer membrane.
16 Therefore,
we monitored Bax translocation and Bax or Bak oligomeri-
zation. As a result, in response to CB irradiation, Bax
translocation from the cytosol to the mitochondria was
detected, and self-oligomerization of Bax and Bak was also
conﬁrmed (Figure 2a). Next, to determine whether Bax and/
or Bak is essential for CB-induced glioma cell death, we
knocked down Bax and/or Bak with siRNAs and also
established T98G/U251 cells stably overexpressing Bcl-2
and B-cell lymphoma-extra large (Bcl-xl), which antagonize
Bax and Bak,
12 and examined their effect on CB-induced
caspase activation and cell death. Both in microscopic
images and quantitation by nuclear staining, CB irradiation-
induced glioma cell death was effectively suppressed not
only by Bcl-2 or Bcl-xl overexpression but also by the double
knockdown of Bax and Bak, whereas single knockdown of
Bax or Bak caused partial inhibition. Essentially similar
results were obtained with respect to CB-induced
cytochrome c release from the mitochondria and caspase
activation including caspase-8 activation (Figure 2b). Thus,
it was indicated that both Bax and Bak are essential
for CB irradiation-induced glioma cell death and that
caspases, including caspase-8, are activated downstream
of mitochondrial proapoptotic Bcl-2 family protein activation.
In this study, we also sought to further examine the
contribution of caspases upstream of mitochondrial Bax
and Bak activation. Therefore, self-oligomerization of Bax
and Bak after CB irradiation in the presence of pan-caspase
inhibitors or speciﬁc caspase inhibitors was monitored.
As a result, in T98G cells, CB irradiation-induced oligomeri-
zation of Bax was not affected by either pan-caspase or
speciﬁc caspase inhibitors, whereas pan-caspase inhibitors
suppressed Bax oligomerization in U251 cells (Supple-
mentary Figure 2).
The MEK–ERK cascade positively regulates CB
irradiation-induced cell death. As the involvement of
MAPKs has been highlighted recently in various cell death-
inducing models, including conventional irradiation-induced
glioma cell death,
17 we next explored the involvement of
MAPKs in CB irradiation-induced glioma cell death. First, we
investigated by immunoblotting analysis the phosphorylation
(¼activation) status of three major MAPKs: extracellular
signal-regulated kinase (ERK), p38 MAPK, and c-Jun
N-terminal kinase (JNK), which have been reported previously
as being correlated with cell death induction. As a result, the
dynamic activation of ERK and p38, but not of JNK, was
observed during 96h after CB irradiation (Figure 3a).
Therefore, we presumed that ERK or p38 MAPK is
involved in CB-induced glioma cell death. To test this
idea, we conducted knockdown experiments using siRNAs
against p38alpha, which constitutes the major p38 isoform,
and against mitogen-activated protein kinase kinase
(MEK)1 and MEK2, which act immediately upstream of
ERK activation.
18 As shown in Supplementary Figure 3a,
knockdown of p38alpha or MEK1/2 speciﬁcally down-
regulated the expression of its respective target and also
suppressed the activation of p38MAPK and ERK1/2,
respectively. In addition, MEK1/2 knockdown inhibited CB
irradiation-induced glioma cell death at 48h, although
p38alpha knockdown rather increased CB-induced T98G
and U251 cell death (Figure 3b). Next, because we wanted to
ask whether the kinase activity of ERK is essential for CB-
induced glioma cell death, we established T98G and U251
cells stably expressing a dominant-negative (DN) ERK2
(Supplementary Figure 3b). T98G and U251 cells stably
expressing the DN ERK2 effectively inhibited CB-induced
cell death compared with nontransfected cells or cells stably
transfected with the empty vector (Figure 3c). Collectively,
these data suggest that the kinase activity of ERK is
essential for glioma cell death. On the basis of these
results, we further examined the impact of MEK1/2 and
p38alpha knockdown on mitochondria-mediated CB-induced
glioma cell death signaling. MEK1/2 knockdown, but not
p38alpha knockdown, inhibited caspases activation, Bax and
Bak activation, and cytochrome c release at 48h in both cell
lines (Figure 3d). Together with these results, it was
considered that the MEK–ERK pathway regulates CB
irradiation-induced glioma cell death upstream of the
mitochondria.
Recovery of activation at 2–36h, but not later than 36h
after CB irradiation, of ERK is essential for CB
irradiation-induced cell death. As ERK activation in
CB-irradiated glioma cells changed dynamically, we
hypothesized that the kinetics of ERK activation has
different roles in CB irradiation-induced glioma cell death.
We noticed three different peaks (0–2, 2–48, and after 48h)
of ERK phosphorylation in CB-irradiated glioma cells
(Figure 3a), and, to test our hypothesis, we tried to
suppress each peak of ERK activation using two different
MEK-speciﬁc inhibitors, as shown schematically in Figure 4a.
Consistent with earlier results (Figure 3), these inhibitors,
when present in the culture medium throughout the assay
period (protocol 4), blocked CB irradiation-induced glioma
cell death signal upstream of the mitochondria and,
consequently, cell death itself (Figure 4b). We then found
that CB irradiation-induced Bax oligomerization, cytochrome
c release from the mitochondria into the cytosol, caspase-3
activation, and cell death are efﬁciently inhibited by protocol 2
(15min to 36h treatment by inhibitors) and slightly by
protocol 3 (treatment by inhibitors after 36h) in both glioma
cell lines (Figure 4c). Collectively, these results suggested
that the recovery of ERK activation during the ﬁrst 36h
after CB irradiation is the most important period for CB
irradiation-induced glioma cell death.
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Cell Death and DiseaseStimulation of the ERK cascade enhances CB irradiation-
induced glioma cell death. With a therapeutic view to these
results, it was important to verify whether glioma cells are killed
by CB irradiation more efﬁciently by applying an ERK-mediated
mechanism. Therefore, to test this idea, we used an ERK
cascade initiator, epidermal growth factor (EGF),
19 and
monitored whether EGF enhanced CB irradiation-induced
glioma cell death. As a result, CB-irradiated glioma cells
pretreated with EGF indicated a continuous activation of ERK
compared with CB treatment alone (Figure 5a). In addition, cell
death, Bax oligomerization, and caspase-3 activation were
signiﬁcantly enhanced by EGF pretreatment, which was
effectively inhibited by different MEK inhibitors (Figure 5b and c;
Supplementary Figure 4). Thus, it was suggested that
stimulation of the ERK cascade could augment CB
irradiation-induced glioma cell death.
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Figure 2 CB irradiation induces mitochondrial Bax and Bak activation upstream of caspase activation, including caspase-8, in T98G and U251 glioma cells. (a) (Upper
panels) T98G and U251 cells were treated with or without CB irradiation (5Gy), and after 48h, the cell lysates obtained were fractionated into cytosol- and mitochondria-rich
fractions.Eachfractionatedprotein samplewas then subjectedto immunoblotting usinganti-Baxandanti-Bakantibodiestomonitor thecytosol–mitochondrial translocation of
Bax and Bak. To conﬁrm equal protein loading of each fraction, the membranes were reprobed using an anti-a-tubulin (for the cytosol) or anti-HSP60 (for the mitochondria)
antibody. As a control of irradiation- or DNA damage-induced responses, cell lysates of T98G and U251 cells obtained at the indicated time points after irradiation by X-ray
(20Gy) or UV-C (UV, 200J) were fractionated and subjected to immunoblotting in the same manner. (Lower panels) T98G and U251 cells were treated as indicated, and the
celllysatesobtainedweresubjectedtoaninvitrocross-linking assayusingtheBMHcross-linker,asdescribedinthe‘Materialsandmethods’section.Thecross-linkedprotein
lysateswerethensubjectedtoimmunoblottingusinganti-Baxandanti-BakantibodiesforthedetectionofBaxandBakoligomers.Asaproteinloadingcontrol,immunoblotting
of proteins from the same samples treated with vehicle (DMSO) instead of cross-linker using anti-Bax and anti-Bak antibodies was also performed. (b) T98G and U251 cells
transfected with control siRNA (Si-control), Bax siRNA (Si-Bax), Bak siRNA (Si-Bak), or Bax and Bak siRNAs (Si-BaxþBak) as described in the ‘Materials and methods’
section, or stably overexpressing empty vector (PCDNA3), Bcl-2 (PCDNA3 Bcl-2), or Bcl-xl (PCDNA3 Bcl-xl) were subjected to CB irradiation (5Gy). After 48h, cells were
harvested and total cell lysates were subjected to immunoblotting using the indicated anti-caspase antibodies. Immunoblotting of the same samples using anti-Bax, anti-Bak,
anti-Bcl-2, and anti-Bcl-xl antibodies was also performed to monitor the efﬁciency of knockdown or overexpression of each protein. The membranes were reprobed using an
anti-a-tubulin antibody to conﬁrm equal protein loading (upper). Quantitation of cell death was also performed (lower), as described in panel b (*Po0.05)
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Figure 3 The MEK–ERK pathway is essential for CB irradiation-induced T98G and U251 glioma cell death. (a) T98G and U251 cells were treated with or without CB
irradiation (5Gy), and the cells were harvested at the indicated time points. Total cell lysates were then subjected to immunoblotting using the indicated antibodies. As a
positivecontrolofJNKactivation,totalcelllysatesofbothcelllinesobtained10minafterUV-C(200J)irradiationwerealsoanalyzedbyimmunoblotting.Themembraneswere
reprobed using an anti-a-tubulin antibody to conﬁrm equal protein loading. (b) T98G and U251 cells transfected with the indicated siRNAs were treated with or without CB
irradiation (5Gy) and subjected to quantitation of cell death 48h after irradiation (*Po0.05). (c) T98G and U251 cells untransfected or stably transfected with a control vector
(Vector) or a dominant-negative ERK2 expression vector were treated with or without CB irradiation (5Gy) and subjected to quantitation of cell death 48h after irradiation.
(d) T98G and U251 cells transfected with control siRNA, MEK1, and MEK2siRNA (set1), or p38alphasiRNA (set1) were treatedwith CB irradiation (5Gy), and after 48h, the
totalcelllysatesobtainedwereanalyzedbyimmunoblottingasdescribedinpanelbforthedetectionofcaspaseactivation(upper).Cross-linkedornoncross-linkedcelllysates
were assayed by immunoblotting for the detection of Bax or Bak oligomers (middle). The obtained cell lysates were fractionated and analyzed by immunoblotting for the
detection of cytochrome c release from the mitochondria into the cytosol (lower)
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Figure 4 Recovered activation of ERK at 2–36h after CB irradiation is essential for CB-induced T98G and U251 glioma cell death. (a) Treatment protocols for MEK
inhibitors (U0126 (U0, 20mM) or PD98059 (PD, 20mM)). Protocol 1 (for selective inhibition of ERK activity at the time of CB irradiation): the inhibitors were present
intheculturemediumfrom2hbeforeandto 30minafterirradiation.Protocol2(forselectiveinhibitionofERKactivityrecoveryoccurring2–36h afterirradiation):theinhibitors
were present 15min to 36h after irradiation.Protocol 3 (for selective inhibition of ERK activity later than 36h after irradiation): the inhibitors were added to the medium at 36h
after irradiation. Protocol 4 (for inhibition of ERK activity throughout the assay period): the inhibitors were added to the culture medium 2h before irradiation. (b) T98G and
U251 cells treated and harvested as indicated in protocol 4 were subjected to quantitation of cell death (*Po0.05), and were also analyzedfor caspase-3 activation, Bax and
Bak oligomerization, and cytochrome c release from the mitochondria into the cytosol. (c) T98G and U251 cells were treated as shown in protocols 1–3. A cell death
assay (*Po0.05), analysis for the detection of caspase-3 activation, Bax oligomerization, and cytochrome c release from the mitochondria into the cytosol were thereafter
carried out
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Cell Death and DiseaseLimited dependence of X-ray-induced glioma cell death
on the MEK–ERK pathway. One of the most important
questions in CB irradiation-induced glioma therapy is
whether CB irradiation kills glioma cell by a different
mechanism compared with X-ray or photon radiotherapies.
As a preliminary study, we found that 20Gy of X-ray induced
T98G and U251 cell death at 72h after irradiation, which was
nearly the same as 48h after 5Gy of CB irradiation in glioma
cell death induction (data not shown). Therefore, we used
this condition of X-ray irradiation. To investigate the
contribution of MEK–ERK cascade to X-ray-induced glioma
cell death, we ﬁrst monitored the activation status of ERK1/2
after X-ray irradiation. The activation status of ERK changes
dynamically for 72h after X-ray irradiation in both T98G and
U251 cells (Figure 6a), although the time kinetics were
different from those of CB irradiation (Figure 3a). From this
result, we presumed that the MEK–ERK cascade might
also be involved in X-ray-induced glioma cell death similar to
CB-induced glioma cell death. Therefore, as a next step, we
tested the effect of MEK inhibitors on X-ray-induced glioma
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Figure 5 Forced sustained activation of ERK by EGF stimulation enhances CB irradiation-induced T98G and U251 glioma cell death. (a) T98G and U251 cells were
treated by CB irradiation (5Gy) with or without EGF (100ng/ml). The cells were then harvested at the indicated time points, and the total cell lysates obtained were analyzed by
immunoblottingtomonitorthestatusofERKactivation.(b)T98GandU251cellsweretreatedbyCBirradiation(5Gy)withorwithoutEGFtreatment(100ng/ml)inthepresenceor
absence of vehicle (DMSO), U0126 (U0, 20mM), or PD98059 (PD, 20mM). At 48h after irradiation, analysis for the detection of caspase-3 activation or Bax oligomerization was
performed. (c) T98G and U251 cells were treated by CB irradiation (5Gy) with or without EGF (100ng/ml) in the presence or absence of U0126 (U0, 20mM) or PD98059 (PD,
20mM). After 72h, photomicrographs of phase-contrast images ( 100) were then obtained using a microscope (left), and cell death was assayed (*Po0.05)
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Cell Death and Diseasecell death. When X-ray-irradiated T98G/U251 cells were
concomitantly treated with MEK inhibitors, cell death was not
affected signiﬁcantly in either glioma cell line, which was not
same as the case of CB irradiation (Figure 6b). Furthermore,
T98G and U251 cells stably expressing a DN ERK2 did not
show signiﬁcantly reduced caspase-3 activation and cell
death after X-ray-irradiation compared with control cells
(Figure 6c). These results suggested that the MEK–ERK
cascade may have a predominant role in CB-induced glioma
cell death compared with X-ray-induced glioma cell death.
Discussion
Although the clinical efﬁcacy of CB-irradiation therapy has
been proven by numerous studies,
1,2 examination of the
detailed molecular effect of CB irradiation on glioma cells is
still unclear. In this study, we showed that CB irradiation-
mediated glioma cell death, especially within 48h after
irradiation, is pure apoptosis by ERK phosphorylation,
mitochondrial proapoptotic Bcl-2 family protein activation,
followed by the activation of caspases. In addition, to the best
of our knowledge, this is the ﬁrst report on the detailed
molecular mechanism of CB irradiation-induced glioma cell
death, including the type of cell death and the detailed
molecular induction mechanism.
In the case of conventional irradiation, in most cases,
irradiated tumor cells have been reported to undergo
apoptosis.
9 Histological analysis of human tumor specimens
also showed necrotic changes as a result of high-dose
irradiation.
10 Furthermore, the involvement of autophagic cell
death was found in photon irradiation-induced glioma cell
suicide.
11 Therefore, in addition to apoptosis, we ﬁrst
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Figure6 TheMEK–ERKpathwaymaynotbeessentialforX-rayirradiation-inducedT98GandU251celldeath.(a)T98GandU251cellsweretreatedwithorwithoutX-ray
irradiation (20Gy), and the cells were harvested at the indicated time points. Total cell lysates were then subjected to immunoblotting using an anti-total ERK1/2 or phospho-
ERK1/2 antibody. Results of different exposure times of phospho-ERK1/2 blot are presented for U251. The membranes were reprobed using an anti-a-tubulin antibody
to conﬁrm equal protein loading. (b) T98G and U251 cells were treated with or without X-ray irradiation (20Gy) in the presence or absence of vehicle (DMSO), U0126
(U0,20mM),or PD98059(PD,20mM). At72h afterirradiation, quantitation ofcelldeath wasthen performed. (c)T98GandU251cellsstablyexpressing adominant-negative
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obtained total cell lysates were subjected to immunoblotting using an anti-caspase-3 antibody (lower). The membranes were reprobed using an anti-a-tubulin antibody
to conﬁrm equal protein loading
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Cell Death and Diseaseexpected thatsuch changeswould also occurin CB-irradiated
glioma cells. However, at least within the ﬁrst few days after
CB irradiation, necrotic cell death did not occurin glioma cells.
Despite increases in autophagic changes being conﬁrmed in
CB-irradiatedT98Gcells,inhibitionofautophagydidnotaffect
cell death (AT and CK, unpublished observation). Therefore,
we considered that the majority of characteristics of CB
irradiation-induced glioma cell death are consistent with
apoptosis.
The involvement of transcription factor p53 in conventional
radiation-induced tumor cell growth arrest/death is generally
recognized, and the efﬁcacy of the p53 gene in the case of CB
irradiation has also already been shown.
20,21 However, tumor
cells with wild-type p53 could have the potential to be treated
effectively by conventional radiation. Furthermore, radio-
resistant gliomas have been reported to have a tendency for
mutationsinthe p53gene.
22Therefore, weused p53-mutated
glioma cell lines in this study to also investigate the detailed
molecular mechanism associated with one of the advantages
of CB irradiation reported previously;
23–25 how CB irradiation
kills p53-mutated tumor cells efﬁciently.
The activation of speciﬁed caspase cascades after various
cell stress stimulation is still ambiguous. In the case of
conventional irradiation especially, the involvement of the
intrinsic pathway, the extrinsic pathway, or both have already
been reported.
9 In the meantime, only the apoptotic pathway
induced by CB irradiation by intrinsic caspase-9 and caspase-
3 activation inp53 wild-type/mutant cellshasbeen reported.
23
In addition, studies on the involvement of extrinsic caspase-8
and supra-mitochondrial involvement of caspases in CB
irradiation-induced tumor cell death had not been examined
before this study, to the best of our knowledge. One difﬁcult
result to comprehend is that pan-caspase inhibitors blocked
not only caspase activation but also Bax activation in CB
irradiation-induced U251 cell death. To clear this question,
two hypotheses were suggested. First, these pan-caspase
inhibitors block an unknown caspase(s) that works upstream
of the mitochondria in multiple cell death-inducing systems of
U251 cells, and second, these inhibitors work by an
unexpected mechanism other than caspase inhibition in
U251 cells, as indicated in previous reports.
26–28 Neither of
these potential mechanisms was demonstrated in the present
experimental system, but there is little doubt that major
known caspases are not involved in the regulation of CB
irradiation-induced glioma cell death upstream of the mito-
chondria in T98G or U251 cells. Another interesting ﬁnding
about the caspase-activation mechanism in this study was
caspase-8 activation downstream of the mitochondria.
Recently, caspase-6 was reported to mediate caspase-3-
induced caspase-8 activation downstream of the mitochon-
dria.
29 Therefore, in the present system, involvement of the
same caspase-8-activating mechanism could be considered.
TheroleofERKincelldeathoftenfocusesonitsprosurvival
function by the downstream transcription of antiapoptotic
genes and downregulation of proapoptotic genes. However,
the proapoptotic action of ERK has been also reported in
different systems. Among these proapoptotic ERK mechan-
isms, the relationship with reactive oxygen species
(ROS)-mediated cell death induction, which is explained by
ROS-induced ERK activation after cell death, has been most
frequently mentioned.
18–22,24–31 However, in the present
model, neither ROS production (Supplementary Figure 5a)
nor the inhibitory effect of antioxidants in CB irradiation-
induced glioma cell death was conﬁrmed (Supplementary
Figure 5b). Thus, unlike cell death induced by other high-dose
DNA damage stresses, which induce ROS-dependent cell
death, it was suggested that gliomas do not produce ROS
even after a maximum clinical dose of CB irradiation, which
may be related to the refractory nature against standard
radiotherapy.
In this study, the recovered activation of ERK observed
2–48h after CB irradiation was considered to have an
essential role in CB irradiation-induced glioma cell death
(Figure 4). However, it should be noted that this peak is not
hyperactivation but recovery of activity up to the baseline
(unstimulated) level in both glioma cell lines. A previous report
indicated a time-dependent increase in ERK activity from the
baseline level corresponding to its cell death-inducing
ability.
32 Furthermore, in the present data, even the complete
suppression of ERK by U0126 did not prevent cell death
completely (Figure 4b), whereas pan-caspase inhibitors
inhibited CB irradiation-induced glioma cell death nearly
completely (Figure 1d). Thus, at least in the present model,
it was suggested that an ERK-independent pathway could
also contribute to CB irradiation-induced glioma cell death.
In considering the mechanism of radiation-induced cell
death, the involvement of receptor-mediated extrinsic cell
death signals, especially those related to Fas-mediated
cell death, have been demonstrated previously,
33 and ERK-
dependent regulation of Fas-mediated cell death was also
demonstrated.
32 Thus, we expected the involvement of the
Fas-mediated extrinsic pathway of apoptosis in the present
system. In addition, we found that the Fas-mediated signal
wasactivatedbothinT98GandinU251cellsonCBirradiation
and was regulated by an ERK-dependent mechanism
(Supplementary Figure 6a). However, an antagonistic-Fas
antibody failed to prevent CB irradiation-induced cell death in
T98G or U251 cells (Supplementary Figure 6b). Therefore, in
the present system, the CB irradiation-induced Fas-mediated
extrinsic pathway of apoptosis was not essential for cell death
induction.
Our data on the EGF-mediated enhancement of CB
irradiation-induced glioma cell killing (Figure 6) was surprising
because in many cases, higher expression of its receptor
EGFR has been described to reﬂect cell refractoriness to
radiotherapy and chemotherapy.
7,34 Usually, EGF stimula-
tion-mediated cell survival mechanisms are explained as
being ERK dependent.
35 However, as described above, ERK
activation has the potential to have a different role in cell fate
against cell stress by different stimuli, even when using the
same cells. Indeed, the preliminary data showed that UV-C
induced both hyperactivation of ERK and cell death in T98G
and U251 cells, but this was not prevented by MEK inhibitors
(data not shown), and X-ray-induced cell death of both glioma
cell lines was also only minimally sensitive to ERK pathway
inhibition (Figure 6). Thus, ERK-mediated augmentation of
glioma cell killing may be speciﬁc to CB irradiation, and
applying a novel ERK-dependent CB irradiation-induced
glioma cell death mechanism in this study, namely the
additionofanERKagonisttreatmenttoCBtherapy(Figure7),
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treatment compared with treatment by CB irradiation alone.
In conclusion, we found in this study that p53-independent
glioma cell death induced by CB irradiation is regulated
through an MEK–ERK–mitochondria–caspase cascade that
may be key to improvement in the clinical outcome of glioma
therapy by radiation. Recently, effective Bcl-2-speciﬁc an-
tagonists
36 or inhibitors of IAP family proteins,
37 which
abrogatecaspaseactivation downstream of the mitochondria,
have been developed. Therefore, treatment by CB irradiation
concomitant with ERK agonists alone or in combination with
theseinhibitors (Figure 7) could be a more effective methodof
treating radioresistant glioma.
Materials and Methods
Reagents and antibodies. U0126 was purchased from A. G. Scientiﬁc
(SanDiego,CA,USA).HumanrecombinantEGFwaspurchasedfromR&DSystem
(Minneapolis, MN, USA). Hoechst 33342 and PD98059 were purchased from
Sigma (St Louis, MO, USA). Tumor necrosis factor-a was purchased from
Genzyme-Techne (Minneapolis, MI, USA). A23187, Boc-Asp-fmk, cycloheximide,
N-acetylcysteine, Trolox, anti-b-tubulin antibody, and anti-p53 antibody were
obtained from Calbiochem (San Diego, CA, USA). Anti-ERK2 antibody, polyclonal
anti-Bak antibody (G-23), polyclonal anti-Bax antibody (N-20), anti-Bcl-2 antibody
(N-19), anti-total JNK2 antibody, and horseradish peroxidase-conjugated anti-goat
IgG secondary antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Anti-Bid antibody, anti-Bip (GRP78) antibody, anti-cytochrome
c antibody, anti-caspase-3 antibody, anti-caspase-8 antibody, anti-caspase-9
antibody, anti-total ERK1/2 antibody, anti-phospho-ERK1/2(Thr180/Tyr182)
antibody, anti-MEK1 antibody, anti-MEK2 antibody, anti-total p38MAPK antibody,
anit-phospho-p38MAPK(Thr202/Tyr204) antibody, anti-phospho-JNK(Thr183/
Tyr185) antibody, and anti-PARP antibody were from Cell Signaling Technology
(San Jose, CA, USA). Bismaleimidohexane (BMH) and a bicinchoninic acid (BCA)
proteinassaykitwerefromThermoScientiﬁc(Rockford,IL,USA).Anti-Fasantibody
and anti-FADD antibody were purchased from BD Transduction Laboratories
(Mississauga, ON, Canada). z-VAD-FMK, Ac-DEVD-CHO, AC-LEHD-CHO, and
AC-IETD-CHO were purchased from Peptide Institute Inc. (Osaka, Japan).
Antagonistic anti-Fas antibody was from MBL (Nagoya, Japan). PI solution,
20,70-dichlorodihydroﬂuorescein diacetate (DCFDA) was from Invitrogen (Eugene,
OR, USA). Lipofectamin 2000 was from Qiagen (Hilden, Germany). QuikChange II
site-directed mutagenesis kit was from Stratagene (La Jolla, CA, USA). Human
placenta total RNA was from Clontech (Mountain View, CA, USA).
siRNAs. Control siRNA, Bax siRNA, MEK1 siRNA, MEK2 siRNA, and p38a
siRNA were purchased from Invitrogen. The sequences of siRNAs for the indicated
target genes were as follows;
Bax: 50-UUGAGCACCAGUUUGCUGGCAAAGU-30;
MEK1 no.1: 50-AAUUCCAGACUGAACACUCCACUGG-30;
MEK1 no.2: 50-AAAGUCGUCAUCCUUCAGUUCUCCC -30;
MEK2 no.1: 50-UUUAUUGACAAACUCCUGGAAGUCG-30;
MEK2 no.2: 50-UUGUGAGCAUCUUCAGGUCCGCCCG-30;
p38a no.1: 50-AAACAAUGUUCUUCCAGUCAACAGC-30;
p38a no.2: 50-UUAGGUCCCUGUGAAUUAUGUCAGC-30.
Bak siRNA was purchased from Qiagen. The sequence was 50-AAGCGAA
GTCTTTGCCTTCTC-30.
Cell lines and cell culture. Human glioblastoma cell lines T98G (purchased
fromRikenBioresourceCenter,Tsukuba,Ibaragi,Japan)andU251(akindgiftfrom
Dr. Mark L Rosenblum, UCSF, San Francisco, CA, USA) seeded in a T25 ﬂask
(Corning, NY, USA) were cultured at 371C in a humidiﬁed 5% CO2 incubator
and were grown in standard Dulbecco’s modiﬁed Eagle’s medium supplemented
with 10% (v/v) fetal bovine serum and antibiotics (100Units/ml penicillin, 100mg/ml
streptomycin) at Yamagata University School of Medicine (Yamagata, Japan). On
the day before CB irradiation, cell growing-ﬂasks were boxed in thermal cases and
carefully carried to the National Institute of Radiologic Science (NIRS) by express
delivery. The cells were then cultured in a CO2 incubator at NIRS continuously
before irradiation.
For X-ray irradiation, cells were cultured in 10cm culture dishes at Yamagata
University School of Medicine.
Irradiation. CB irradiation (290MeV, 6cm spread-out Bragg peak (SOBP)) was
performed using the heavy ion accelerator in Chiba (HIMAC) at the NIRS as
described previously.
23 Cell culture ﬂasks were ﬁxed vertically in the center of the
SOBP, and accelerated carbon ions (1–10Gy) were irradiated using the protocol
compatible with the ﬂask structure by horizontal beam. After irradiation, cells
scheduled for assay 24h or later after irradiation were immediately trypsinized and
passagedinto culturedishes,whichwerekeptculturingagaininaCO2incubatorfor
the following experiments. Cells scheduled for assay within 24h after irradiation
were kept maintained in the irradiated ﬂask in a CO2 incubator.
The reference radiation was X-rays and the radiation dose was measured using
an ionization chamber, and UV-C was delivered automatically in a Spectrolinker
XL-1000 (Spectronics Corporation, Westburg, NY, USA) after aspiration of the
culture medium.
Construction of plasmids. An expression vector for DN MAPK kinase
(MEK–ERK–KR) was constructed as described previously with slight
modiﬁcations.
38 Human placenta total RNA was reverse transcribed. cDNAs
encodingtheERK2andMEK1weresubclonedintopcDNA3vector.Mutagenesisof
K54 in the human ERK2 to arginine and of the four leucine residues in the human
MEK1 nuclear export sequence to alanine was performed using a QuikChange II
site-directed mutagenesis kit. Expression vectors for Bcl-2 and Bcl-xl were
constructed as described previously.
39
Transfection. Transfection of siRNAs or plasmids into glioma cells was
performed usingLipofectamin 2000 inaccordancewith the manufacturer’s protocol.
When transfection was performed combined with CB irradiation, transfection was
performed 6h before CB irradiation, and in the case of UV irradiation, it was
performed 24h before UV irradiation. For siRNA transfection, a 150nM siRNA per
array was used. Stable T98G or U251 transfectants by transfecting both cells with
CB  irradiation
MEK-ERK re-activation
after initial down-regulation
Mitochondria
Caspase-3, 8, 9 activation
Apoptosis
FAS↑ 
Bax / Bak activation and
Mitochondrial outer-membrane
permeabilization
New targets for
glioma therapy
by CB 
Figure 7 Schematic summary of the present ﬁndings. On the basis of the
results of the current study, we propose that CB irradiation triggers reactivation of
the MEK–ERK pathway subsequent to initial downregulation, which then initiates
the mitochondrial pathway of caspase cascade activation, culminating in apoptotic
death of glioma cells. Molecules involved in this cell death signaling pathway could
be new targets for augmentation of CB therapy against gliomas. For instance, EGF
may be used for MEK–ERK pathway activation, ABT-737 for the activation of
mitochondrial apoptosis, and SMAC mimetics for caspase cascade activation
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eachtransfectant,multipleclonesexpressingtheintendedproteinweresubjectedto
thesubsequentanalyses,andessentiallysimilarresultswereobtainedfrommultiple
clones.Therefore,foreachtransfectants,resultsfromtworepresentativeclonesare
presented.
Celldeathandapoptosisassays. Celldeathandapoptosiswereassayed
at the time points indicated in the ﬁgure legends after treatment with cell death
stimuli.CelldeathwasdetectedbasedontheinabilityofcellstoexcludevitaldyePI.
In brief, 4.0mg/ml PI and 100mM Hoechst 33342 were added to the cell culture
medium directly at the time point of the assay, and the cells were cultured in a CO2
incubator for 10min. The cellular nuclei were then stained with Hoechst 33342 and
PIwerecountedindependentlyusingaﬂuorescencemicroscope(CKX41;Olympus,
Tokyo, Japan; at least 500 cells per sample were assayed), and the percentage of
PI-positive cells to total Hoechst-positive cells was calculated. For quantitation of
apoptosis, cells were stained with Hoechst 33342 and PI as described above, and
the percentage of apoptotic cells, in which the nuclei were PI positive in addition to
beingcondensedandfragmented,tototalHoechst-positivecellswasdetermined(at
least of 500 cells per sample were assayed).
Preparation of cell lysate, cell fractionation, and immuno-
blotting. Whole-cell lysates were obtained as described previously.
16 Cell
fractionation was also performed as described previously
16 with minor
modiﬁcations. In brief, pelleted cells were permeabilized for 1min in isotonic
buffercontaining0.03%digitoninfor5minoniceandthencentrifugedat15000 g
for 10min. The supernatant (cytosolic fraction) and the pellet (mitochondrial
fraction) were collected, and the pellet was further lysed as the ﬁnal mitochondrial
lysate. For immunoblotting, the protein concentration of the lysates was determined
using a BCA protein assay kit in accordance with the manufacturer’s instructions.
Equal amounts of protein were separated by 8–15% SDS-PAGE and then
transferred onto a PDVF membrane. Membranes were blocked at room
temperature for 1h in blocking buffer (5% skim milk and 0.1% Tween 20 in TBS
(TBS-T), 1:500 dilution) and then incubated overnight with a primary antibody
(1:1500 dilution) diluted in blocking buffer at 41C. The membranes were then
washedthreetimeswith TBS-T,incubatedwitha peroxidase-conjugatedsecondary
antibody diluted in the antibody buffer (1:10000 dilution) at room temperature for
1h, and washed three times with TBS-T. Membrane-bound antibodies were
visualized using western chemiluminescent HRP substrate.
In vitro cross-linking for the detection of Bax and Bak
oligomers. In vitro cross-linking of associated Bax or Bak monomers was
performed according to the method reported previously
16 with some modiﬁcations.
In brief, collected cells were lysed in cross-linking buffer (10mM HEPES (pH 7.5),
10mM KCl, 1.5mM MgCl2, 1mM EDTA, 1mM EGTA, 1mM dithiothreitol, 250mM
sucrose, 2% CHAPS) on ice for 30min, and then BMH dissolved in DMSO was
added to a ﬁnal concentration of 10mM. After incubation for 30min at room
temperature with rotation, the lysate was centrifuged at 15000 g for 10min. The
supernatant was collected as cross-linked lysate, and after determination of the
protein concentration using a BCA protein assay kit, the lysate was subjected to
immunoblotting analysis using polyclonal anti-Bax and anti-Bak antibodies.
Formation of homo-oligomers was judged by their molecular weight.
16
Quantitation of active caspase-3/Bax oligomerization. For
quantitation of caspase-3 activation and Bax oligomerization, densitometric
analysis of cleaved caspase-3 and Bax oligomerized (dimer) bands was
performed using Quantity One software (Bio-Rad, Tokyo, Japan). The results
were normalized to a-tubulin for cleaved caspase-3 and to HSP60 (heat-shock
protein 60) for Bax dimer.
DNA ladder formation assay. DNA ladder formation assay was performed
as described previously.
40 A total of 1 10
7 cells were used for each sample.
Measurement of the levels of intracellular ROS. Detection of
intracellular ROS by DCFDA was performed as we reported previously.
16
Visualization and calculation of intracellular ROS was performed using a
ﬂuorescence microscope (CKX41; Olympus, Tokyo, Japan) and DPController
software(Olympus)usinga manualprotocol (singleexposure,exposuretime0.1s).
Statistical analysis. For all experiments with quantitative results, data are
expressed as mean and S.D. from three identical experiments. Difference of means
wastested byStudent’st-test usingMicrosoftExcel2007 software(MicrosoftCorp.,
Richmond, WA, USA). P-values o0.05 were considered statistically signiﬁcant.
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